Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled multicenter study of doxylamine succinate tablets for short-term insomnia disorder
CTR20252123Phase 2Active
- Sponsor
- Jiangxi Xinganjiang Pharmaceutical
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of doxylamine in Insomnia, sponsored by Jiangxi Xinganjiang Pharmaceutical. Started May 2025; status: active.
02
Drugs
doxylamine
03
Conditions
Insomnia
Beyond the preview
Go deeper on CTR20252123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252123.